TET2 c.2156del ;(p.L719Cfs*32)

Variant ID: 4-106157251-CT-C

NM_001127208.2(TET2):c.2156del;(p.L719Cfs*32)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Mutation status and burden can improve prognostic prediction of patients with lower-risk myelodysplastic syndromes.

Cancer Science
Jiang, Lingxu L; Luo, Yingwan Y; Zhu, Shuanghong S; Wang, Lu L; Ma, Liya L; Zhang, Hua H; Shen, Chuying C; Yang, Wenli W; Ren, Yanling Y; Zhou, Xinping X; Mei, Chen C; Ye, Li L; Xu, Weilai W; Yang, Haiyang H; Lu, Chenxi C; Jin, Jie J; Tong, Hongyan H
Publication Date: 2020-02

Variant appearance in text: TET2: 2153delT
PubMed Link: 31804030
Variant Present in the following documents:
  • Main text
  • CAS-111-580.pdf
View BVdb publication page



appreci8: a pipeline for precise variant calling integrating 8 tools.

Bioinformatics (Oxford, England)
Sandmann, Sarah S; Karimi, Mohsen M; de Graaf, Aniek O AO; Rohde, Christian C; Göllner, Stefanie S; Varghese, Julian J; Ernsting, Jan J; Walldin, Gunilla G; van der Reijden, Bert A BA; Müller-Tidow, Carsten C; Malcovati, Luca L; Hellström-Lindberg, Eva E; Jansen, Joop H JH; Dugas, Martin M
Publication Date: 2018-12-15

Variant appearance in text: TET2: 2156delT; Leu719fs
PubMed Link: 29945233
Variant Present in the following documents:
  • bty518_supplementary_data_s10.xlsx, sheet 8
View BVdb publication page